欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > DNADamage/DNARepair > Tretazicar

浏览历史

S89139

Tretazicar

源叶(MedMol) 98%
  • 英文名:
  • Tretazicar
  • 别名:
  • CB1954; CB-1954; CB 1954; Tretazicar
  • CAS号:
  • 21919-05-1
  • 分子式:
  • C9H8N4O5
  • 分子量:
  • 252.18
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S89139-5mg 98% ¥164.00元 7 - - - EA 加入购物车
源叶(MedMol) S89139-10mg 98% ¥246.00元 8 - - - EA 加入购物车
源叶(MedMol) S89139-50mg 98% ¥710.00元 4 - - - EA 加入购物车
源叶(MedMol) S89139-200mg 98% ¥2830.00元 2 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: Tretazicar (CB 1954), an antitumor proagent, is highly selective against the Walker 256 rat tumour line. Tretazicar is enzymatically activated to generate a bifunctional agent, which can form DNA-DNA interstrand cross-links. Tretazicar in rat cells involves the reduction of its 4-nitro group to a 4-hydroxylamine by the enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1)
  • 靶点: DNA Alkylator/Crosslinker;DNAAlkylator/Crosslinker; DNAAlkylation
  • 体外研究:
    Tretazicar (CB 1954) (0.1-1000 μM; 3 days) has sensitivity for retrovirally transduced AB22 (AB22-nr) cells with an IC50 of 3 μM.
    DNA cross-link formation in affected cells is a result of the bioactivation of the drug by the enzyme DT diaphorase (NAD(P)H dehydro-genase (quinone)) in the Walker cells which reduces the 4-nitro group of Tretazicar. The product of this reaction is a difunctional alkylating agent, 5-aziridin-1-yl-4-hydroxylamino-2-nitrobenzamide。
  • 体内研究:
    Tretazicar (CB 1954) (80 mg/kg; i.p. on days 2 and 9) results in a significant increase in survival. Animal Model: Female BALB/c mice (AB22-nr, SKOV3 human ovarian tumour xenograft) Dosage: 80 mg/kg Administration: i.p. on days 2 and 9 Result: The median survival of the AB22-nr was 49 days. Resulted in a significant increase in survival.
  • 参考文献:
    1. Knox RJ,et al. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Cancer Res. 2000 Aug 1;60(15):4179-86. 2. Knox RJ, et al. CB 1954: from the Walker tumor to NQO2 and VDEPT. Curr Pharm Des. 2003;9(26):2091-104. 3. Green NK, et al. Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronicadenovirus vector. Int J Cancer. 2003 Mar 10;104(1):104-12. 4. Drabek D, et al. The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954. Gene Ther. 1997 Feb;4(2):93-100.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 3.965 ml 19.827 ml 39.654 ml
    5 mM 0.793 ml 3.965 ml 7.931 ml
    10 mM 0.397 ml 1.983 ml 3.965 ml
    50 mM 0.079 ml 0.397 ml 0.793 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。